Injective has stayed far quieter than during its earlier surge, and INJ price has followed the same direction. Momentum that once carried the project toward multibillionInjective has stayed far quieter than during its earlier surge, and INJ price has followed the same direction. Momentum that once carried the project toward multibillion

Injective (INJ) Down 90% After $4B Hype: Were the Warning Signs Always There?

2026/02/14 21:15
1 min read
Injective has stayed far quieter than during its earlier surge, and INJ price has followed the same direction. Momentum that once carried the project toward multibillion valuation has faded into a prolonged correction. One analyst now argues that the decline did not appear suddenly. Signals of weakness may have existed long before the fall became
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.